[1]
M. B. Liester, B. Liang, and L. Schwartz, “The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity”, J Neurol Res, vol. 16, no. 3, pp. 127–140, Jan. 2026, doi: 10.14740/jnr1115.